Table 3.
Frequency of aortic arch defects at E18.5 after timed ablation of Fgf8 in the Tbx1 domain
Genotype | E7.5 | E8.5 | E9.5 |
---|---|---|---|
Abnormal/Total | |||
Tbx1mcm/+; Fgf8+/+ | 16/41 (39%)*,^ | ||
Tbx1mcm/+; Fgf8+/− | 29/37 (78%)* | ||
Tbx1mcm/+; Fgf8flox/+ | 16/31 (52%) | 10/31 (32%) | 19/31 (63%)^ |
Tbx1mcm/+; Fgf8flox/− | 21/26 (81%) | 28/32 (88%) | 33/37 (89%) |
Comparison of Tbx1mcm/+; Fgf8+/+ and Tbx1mcm/+; Fgf8+/− reconfirmed that Tbx1 and Fgf8 interact in vivo as the frequency of defects increases significantly in Tbx1mcm/+; Fgf8+/− embryos (*P = 0.006). Tbx1-driven deletion of one copy of Fgf8 in Tbx1mcm/+; Fgf8flox/+ embryos exposed to TM at E9.5 is sufficient to recapitulate the effect of germ-line ablation of Fgf8, since the frequency of defects in E9.5 induced Tbx1mcm/+; Fgf8flox/+ embryos is significantly greater that in Tbx1mcm/+; Fgf8+/+ (^P = 0.04) and closely approached the frequency seen in Tbx1mcm/+; Fgf8+/− (78% vs. 63%; P = 0.2).